ClinicalTrials.Veeva

Menu

Norepinephrine Weaning in Septic Patients (CATECHOFLOU)

A

Association pour le Développement de la Recherche et de l'Enseignement en Médecine d'Urgence

Status and phase

Completed
Phase 4

Conditions

Septic Shock

Treatments

Device: norepinephrine infused under computerized fuzzy logic control
Device: norepinephrine infused at the clinician's discretion

Study type

Interventional

Funder types

Other

Identifiers

NCT00763906
DH/JF-11-2002

Details and patient eligibility

About

The weaning rate of vasopressors drugs is usually chosen empirically by the clinician in critically patients. The investigators applied fuzzy logic principles to modify intravenous norepinephrine infusion rates during norepinephrine infusion in septic patients in order to reduce the duration of shock. The investigators goal was to reduce the duration of poorly controlled hemodynamic status.

Enrollment

40 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Septic shock

Exclusion criteria

  • Less than 18 years
  • Pregnancy
  • Weight above 135 kg
  • Requirement for continuous epinephrine infusion
  • Severe head injury, stroke, a comatose state following cardiac arrest

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

40 participants in 2 patient groups, including a placebo group

1
Placebo Comparator group
Description:
Patients were assigned to norepinephrine infused at the clinician's discretion.
Treatment:
Device: norepinephrine infused at the clinician's discretion
2
Active Comparator group
Description:
Patients were assigned to norepinephrine infused under computerized fuzzy logic control.
Treatment:
Device: norepinephrine infused under computerized fuzzy logic control

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems